As for the TCGA-BLCA biomarkers (Table 6), among the DNA-methylation features, CALN1 hypomethylation has been proposed as a urinary diagnostic marker that stratifies high-risk, nonmuscle-invasive bladder cancer patients and improves recurrence prediction models [46]. Here, CALN1 is linked to urinary bladder carcinoma.